← Back to Markets

APUS

Apimeds Pharmaceuticals US Inc · NYSE MKT LLC · Biotechnology

$1.88+$0.13 (+7.43%)

Prices delayed up to 5 minutes

AC Intelligence

AC Intelligence

AC Intelligence for APUS is being prepared.

Key Stats

Key Stats

Open

$1.69

Day High

$1.89

Day Low

$1.69

Prev Close

$1.75

Volume

0

Avg Volume

Day Change

+$0.13

Change %

+7.43%

Fundamentals

Earnings History

Insider Activity

Who Owns This Stock

Who Owns APUS

Other76.1%3 holders
Passive / Index23.7%2 holders

Based on Q4 2025 13F filings + AC behavioral model

7 institutional holders

Top Holders

1.Hemenway Trust Co LLC
+9.6%$449.4B
2.Vanguard Group
+45.4%$57.3B
3.Geode Capital Management
$52.8B
4.JANE STREET GROUP, LLC
$44.6B
5.Vanguard Group
0.0%$39.4B
6.Geode Capital Management
+123.2%$4.4B
7.UBS Group AG
$954M
8.Bank of America Corp
$61M
9.Tower Research Capital LLC (TRC)
$16M
10.Bank of America Corp
+200.0%$5M

Institutional Pressure

Market Regime:Strong Risk-Off (-0.62)
SELLINGBUYING
Neutral
Other(76.1%)
Passive / Index(23.7%)
Holds
Dealer / Bank(0.2%)
Facilitating

24% passive + quality floor won't sell.

Updated daily · Based on Q4 2025 filings + AC behavioral model

Sentiment Signals

Sentiment Signals

Insider ActivityNo insider transactions in last 90 daysSEC Form 4
↑↑Inst. Flows9 increased/new, 0 decreased/exited (13F)AC 13F Analysis

Sources: SEC Form 4, AC 13F Analysis

On AcidCapitalist

On AcidCapitalist

No recent mentions of APUS on AcidCapitalist.

Data provided by Finnhub. Prices delayed up to 5 minutes.